Logo image of SABR

SABRE CORP (SABR) Stock Fundamental Analysis

USA - NASDAQ:SABR - US78573M1045 - Common Stock

1.77 USD
-0.04 (-2.21%)
Last: 9/25/2025, 8:00:02 PM
1.78 USD
+0.01 (+0.56%)
After Hours: 9/25/2025, 8:00:02 PM
Fundamental Rating

3

Taking everything into account, SABR scores 3 out of 10 in our fundamental rating. SABR was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. SABR has a bad profitability rating. Also its financial health evaluation is rather negative. SABR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

SABR had negative earnings in the past year.
In the past year SABR has reported a negative cash flow from operations.
SABR had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: SABR reported negative operating cash flow in multiple years.
SABR Yearly Net Income VS EBIT VS OCF VS FCFSABR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

SABR has a Return On Assets of -8.11%. This is amonst the worse of the industry: SABR underperforms 82.09% of its industry peers.
With a decent Return On Invested Capital value of 7.86%, SABR is doing good in the industry, outperforming 63.43% of the companies in the same industry.
Industry RankSector Rank
ROA -8.11%
ROE N/A
ROIC 7.86%
ROA(3y)-8.94%
ROA(5y)-13.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SABR Yearly ROA, ROE, ROICSABR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

SABR has a better Operating Margin (11.73%) than 63.43% of its industry peers.
SABR's Operating Margin has improved in the last couple of years.
SABR's Gross Margin of 57.79% is fine compared to the rest of the industry. SABR outperforms 70.90% of its industry peers.
SABR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.73%
PM (TTM) N/A
GM 57.79%
OM growth 3YN/A
OM growth 5Y1.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y17.88%
SABR Yearly Profit, Operating, Gross MarginsSABR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SABR is still creating some value.
Compared to 1 year ago, SABR has more shares outstanding
Compared to 5 years ago, SABR has more shares outstanding
The debt/assets ratio for SABR is higher compared to a year ago.
SABR Yearly Shares OutstandingSABR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
SABR Yearly Total Debt VS Total AssetsSABR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

SABR has an Altman-Z score of -0.45. This is a bad value and indicates that SABR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.45, SABR is not doing good in the industry: 85.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.45
ROIC/WACC1.07
WACC7.31%
SABR Yearly LT Debt VS Equity VS FCFSABR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

A Current Ratio of 1.01 indicates that SABR should not have too much problems paying its short term obligations.
SABR has a Current ratio (1.01) which is in line with its industry peers.
A Quick Ratio of 1.01 indicates that SABR should not have too much problems paying its short term obligations.
SABR has a Quick ratio (1.01) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01
SABR Yearly Current Assets VS Current LiabilitesSABR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

SABR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.00%, which is quite impressive.
SABR shows a decrease in Revenue. In the last year, the revenue decreased by -1.16%.
SABR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.29% yearly.
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y21.5%
Revenue growth 5Y-5.29%
Sales Q2Q%-10.44%

3.2 Future

Based on estimates for the next years, SABR will show a very strong growth in Earnings Per Share. The EPS will grow by 30.59% on average per year.
SABR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.90% yearly.
EPS Next Y112.08%
EPS Next 2Y82.02%
EPS Next 3Y51.1%
EPS Next 5Y30.59%
Revenue Next Year-7.22%
Revenue Next 2Y-1.81%
Revenue Next 3Y-0.28%
Revenue Next 5Y0.9%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SABR Yearly Revenue VS EstimatesSABR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
SABR Yearly EPS VS EstimatesSABR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 -1 -2 -3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

SABR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 7.09 indicates a rather cheap valuation of SABR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SABR indicates a rather cheap valuation: SABR is cheaper than 94.78% of the companies listed in the same industry.
SABR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.64.
Industry RankSector Rank
PE N/A
Fwd PE 7.09
SABR Price Earnings VS Forward Price EarningsSABR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SABR.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.57
SABR Per share dataSABR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SABR's earnings are expected to grow with 51.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y82.02%
EPS Next 3Y51.1%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SABR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SABRE CORP

NASDAQ:SABR (9/25/2025, 8:00:02 PM)

After market: 1.78 +0.01 (+0.56%)

1.77

-0.04 (-2.21%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners92.93%
Inst Owner Change2.85%
Ins Owners2.95%
Ins Owner Change13.97%
Market Cap698.28M
Analysts78.33
Price Target2.76 (55.93%)
Short Float %7.34%
Short Ratio3.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-294.41%
Min EPS beat(2)-488.82%
Max EPS beat(2)-100%
EPS beat(4)0
Avg EPS beat(4)-150.79%
Min EPS beat(4)-488.82%
Max EPS beat(4)-2.3%
EPS beat(8)3
Avg EPS beat(8)-58.96%
EPS beat(12)5
Avg EPS beat(12)-37.14%
EPS beat(16)8
Avg EPS beat(16)-25.12%
Revenue beat(2)0
Avg Revenue beat(2)-5.36%
Min Revenue beat(2)-6.19%
Max Revenue beat(2)-4.52%
Revenue beat(4)0
Avg Revenue beat(4)-4.06%
Min Revenue beat(4)-6.19%
Max Revenue beat(4)-2.22%
Revenue beat(8)1
Avg Revenue beat(8)-2.36%
Revenue beat(12)2
Avg Revenue beat(12)-2.74%
Revenue beat(16)3
Avg Revenue beat(16)-1.94%
PT rev (1m)-41.34%
PT rev (3m)-40.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-55.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-82.14%
Revenue NQ rev (1m)-2.39%
Revenue NQ rev (3m)-6.01%
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)-7.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.09
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 11.57
EPS(TTM)-0.14
EYN/A
EPS(NY)0.25
Fwd EY14.1%
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS7.46
BVpS-4.61
TBVpS-11.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.11%
ROE N/A
ROCE 9.95%
ROIC 7.86%
ROICexc 8.96%
ROICexgc 75.68%
OM 11.73%
PM (TTM) N/A
GM 57.79%
FCFM N/A
ROA(3y)-8.94%
ROA(5y)-13.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y5.08%
OM growth 3YN/A
OM growth 5Y1.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y17.88%
F-Score3
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.86
Cap/Depr 65.67%
Cap/Sales 2.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z -0.45
F-Score3
WACC7.31%
ROIC/WACC1.07
Cap/Depr(3y)53.81%
Cap/Depr(5y)40.03%
Cap/Sales(3y)2.84%
Cap/Sales(5y)3.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y112.08%
EPS Next 2Y82.02%
EPS Next 3Y51.1%
EPS Next 5Y30.59%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y21.5%
Revenue growth 5Y-5.29%
Sales Q2Q%-10.44%
Revenue Next Year-7.22%
Revenue Next 2Y-1.81%
Revenue Next 3Y-0.28%
Revenue Next 5Y0.9%
EBIT growth 1Y32%
EBIT growth 3YN/A
EBIT growth 5Y-3.45%
EBIT Next Year50.35%
EBIT Next 3Y19.29%
EBIT Next 5Y8.23%
FCF growth 1Y-8.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.38%
OCF growth 3YN/A
OCF growth 5Y-34.35%